The trademark application BEZYNVI was filed by Actelion Pharmaceuticals Ltd., a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on May 5, 2022, and it was registered by office on August 12, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).